-
Product Insights
NUT Midline Carcinoma (NMC or Nuclear Protein in Testis Midline Carcinoma) - Drugs In Development, 2024
Empower your strategies with our NUT Midline Carcinoma (NMC or Nuclear Protein in Testis Midline Carcinoma) – Drugs In Development, 2024 report and make more profitable business decisions. Nuclear protein in testis (NUT) midline carcinoma (NMC) is a rare and aggressive cancer that can grow anywhere in the body. It is caused by rearrangement of the NUTM1 gene. Symptoms include fatigue, weight loss, a painless lump, pain, persistent cough, and shortness of breath. NMC is difficult to diagnose and treat. There...
-
Product Insights
Pediatric Cancer - Drugs In Development, 2024
Empower your strategies with our Pediatric Cancer – Drugs In Development, 2024 report and make more profitable business decisions. Pediatric cancer types include leukemias, brain and other central nervous system (CNS) tumors, and lymphomas. Signs and symptoms include unexplained paleness and loss of energy, easy bruising or bleeding, limping, fever, and headaches. Diagnosis can be done by blood tests, biopsy, ultrasound, MRI, and PET-CT scan. Common treatments include surgery, chemotherapy, radiation therapy, immunotherapy, and stem cell transplant. The Pediatric Cancer drugs...
-
Product Insights
Acostic Neuroma (Auditory Nerve Tumor) - Drugs In Development, 2024
Empower your strategies with our Acostic Neuroma (Auditory Nerve Tumor) – Drugs In Development, 2024 report and make more profitable business decisions. Acostic neuroma or vestibular schwannoma is a noncancerous, usually slow growing tumor affecting balance and auditory nerves. It is of two types: sporadic unilateral acoustic neuroma and genetic, bilateral acoustic neuroma. Hearing loss, dizziness, tinnitus, eye fullness, balance problems and vertigo, numbness in the face, and swallowing problems are some of the signs and symptoms. It can be diagnosed...
-
Product Insights
Choriocarcinoma (Gestational Trophoblastic Neoplasia) - Drugs In Development, 2024
Empower your strategies with our Choriocarcinoma (Gestational Trophoblastic Neoplasia) – Drugs In Development, 2024 report and make more profitable business decisions. Gestational trophoblastic disease (GTD) is a group of rare tumors that develop during the early stages of pregnancy. Most GTD tumors are benign (noncancerous), but some may turn into malignant (cancerous). GTD is categorized into hydatidiform moles and gestational trophoblastic neoplasia (GTN). Risk factors include age younger than 20 or older than 35, previous molar pregnancy, and history of miscarriage....
-
Product Insights
Clear Cell Squamous Cell Carcinoma - Drugs In Development, 2024
Empower your strategies with our Clear Cell Squamous Cell Carcinoma  – Drugs In Development, 2024 report and make more profitable business decisions. Clear cell squamous cell carcinoma (SCC), or hydropic SCC, is an extremely rare variant of SCC. It may be caused by ultraviolet radiation. It is usually not life-threatening, but if left untreated, it can grow large or spread to other parts of the body. Symptoms include a rough, reddish, scaly area; a dome-shaped or wart-like growth; a new...
-
Product Insights
Colorectal Tumor - Drugs In Development, 2024
Empower your strategies with our Colorectal Tumor – Drugs In Development, 2024 report and make more profitable business decisions. Colorectal cancer, or colon cancer, is a disease where cells in the colon or rectum grow out of control. Most colorectal cancers start as polyps, which are growths on the inner lining of the colon or rectum. Risk factors for colorectal cancer include increased age. Symptoms include change in bowel habits, rectal bleeding or blood in the stool, abdominal discomfort, weakness, and...
-
Product Insights
Humoral Hypercalcemia of Malignancy - Drugs In Development, 2024
Empower your strategies with our Humoral Hypercalcemia of Malignancy – Drugs In Development, 2024 report and make more profitable business decisions. Humoral hypercalcemia of malignancy (HHM) is caused by too much parathyroid hormone-related peptide (PTHrP) from malignant tumors. Primary hyperparathyroidism, PTH production by malignant cells, local osteolytic hypercalcemia, ectopic hyperparathyroidism, and vitamin D-secreting lymphomas can cause HHM. Symptoms include anxiety, depression, cognitive dysfunction, lethargy, weakness, fatigue, hyporeflexia, confusion, stupor, and in the most severe cases, coma. PTH and vitamin D levels,...
-
Product Insights
Mast Cell Leukemia - Drugs In Development, 2024
Empower your strategies with our Mast Cell Leukemia – Drugs In Development, 2024 report and make more profitable business decisions. Mast cell leukemia (MCL) is a rare and aggressive type of blood cell cancer. It is a subtype of systemic mastocytosis (SM) and caused by the abnormal growth of cells from myeloid progenitor cells. Symptoms include lethargy and weakness, fainting, flushing, fever, tachycardia, losing more than 10 percent of body weight, diarrhea, nausea, and vomiting. MCL diagnosis requires fulfillment of diagnostic...
-
Product Insights
Vestibular Schwannoma (Acoustic Neuroma) - Drugs In Development, 2024
Empower your strategies with our Vestibular Schwannoma (Acoustic Neuroma) – Drugs In Development, 2024 report and make more profitable business decisions. Vestibular schwannoma is a benign, slow-growing tumor that develops from the balance and hearing nerves. It is also called an acoustic neuroma/neurinoma/neurilemma and is mainly caused by overproduction of Schwann cells. It affects the hearing and balance nerves, causing unilateral or asymmetric hearing loss, tinnitus, and dizziness/loss of balance. It can be diagnosed by thorough ear examination and hearing and...
-
Product Insights
Metastatic Bile Duct Cancer - Drugs In Development, 2024
Empower your strategies with our Metastatic Bile Duct Cancer – Drugs In Development, 2024 report and make more profitable business decisions. Cholangiocarcinoma, also known as bile duct cancer, is a type of cancer that forms in the bile ducts. Symptoms of cholangiocarcinoma may include abdominal pain, yellowish skin, weight loss, generalized itching, and fever. Light colored stool or dark urine may also occur. The Metastatic Bile Duct Cancer drugs in development market research report provide comprehensive information on the therapeutics under...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.